nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—Cloperastine—Raloxifene—breast cancer	0.174	1	CrCrCtD
Azelastine—CYP1A1—breast cancer	0.0836	0.343	CbGaD
Azelastine—CYP2D6—breast cancer	0.0622	0.255	CbGaD
Azelastine—CYP3A4—breast cancer	0.0533	0.219	CbGaD
Azelastine—ABCB1—breast cancer	0.0444	0.182	CbGaD
Azelastine—CYP2A6—Letrozole—breast cancer	0.0347	0.0883	CbGbCtD
Azelastine—CYP1A1—Toremifene—breast cancer	0.0242	0.0615	CbGbCtD
Azelastine—CYP2B6—Thiotepa—breast cancer	0.0153	0.0388	CbGbCtD
Azelastine—CYP1A2—Anastrozole—breast cancer	0.0118	0.03	CbGbCtD
Azelastine—CYP1A2—Toremifene—breast cancer	0.0108	0.0275	CbGbCtD
Azelastine—CYP2C9—Anastrozole—breast cancer	0.0106	0.0271	CbGbCtD
Azelastine—CYP3A5—Lapatinib—breast cancer	0.0106	0.0269	CbGbCtD
Azelastine—CYP2A6—Tamoxifen—breast cancer	0.0103	0.0263	CbGbCtD
Azelastine—CYP2B6—Raloxifene—breast cancer	0.0102	0.0259	CbGbCtD
Azelastine—CYP2C8—Lapatinib—breast cancer	0.0102	0.0259	CbGbCtD
Azelastine—ABCB1—Toremifene—breast cancer	0.00945	0.024	CbGbCtD
Azelastine—CYP1A1—Tamoxifen—breast cancer	0.00884	0.0225	CbGbCtD
Azelastine—CYP2C19—Lapatinib—breast cancer	0.00854	0.0217	CbGbCtD
Azelastine—CYP3A4—Exemestane—breast cancer	0.00817	0.0208	CbGbCtD
Azelastine—CYP2C9—Idarubicin—breast cancer	0.00807	0.0205	CbGbCtD
Azelastine—CYP2C8—Raloxifene—breast cancer	0.00772	0.0196	CbGbCtD
Azelastine—CYP2A6—Fluorouracil—breast cancer	0.00762	0.0194	CbGbCtD
Azelastine—CYP2D6—Idarubicin—breast cancer	0.00738	0.0188	CbGbCtD
Azelastine—CYP3A4—Letrozole—breast cancer	0.00695	0.0177	CbGbCtD
Azelastine—ABCB1—Lapatinib—breast cancer	0.00689	0.0175	CbGbCtD
Azelastine—CYP2E1—Tamoxifen—breast cancer	0.00683	0.0174	CbGbCtD
Azelastine—CYP2B6—Tamoxifen—breast cancer	0.00673	0.0171	CbGbCtD
Azelastine—CYP2E1—Mitoxantrone—breast cancer	0.00666	0.0169	CbGbCtD
Azelastine—CYP3A4—Anastrozole—breast cancer	0.00619	0.0157	CbGbCtD
Azelastine—CYP3A4—Toremifene—breast cancer	0.00566	0.0144	CbGbCtD
Azelastine—CYP3A5—Tamoxifen—breast cancer	0.0053	0.0135	CbGbCtD
Azelastine—CYP3A4—Fulvestrant—breast cancer	0.00526	0.0134	CbGbCtD
Azelastine—CYP2B6—Irinotecan—breast cancer	0.00517	0.0131	CbGbCtD
Azelastine—CYP2C8—Tamoxifen—breast cancer	0.0051	0.013	CbGbCtD
Azelastine—CYP3A4—Thiotepa—breast cancer	0.00469	0.0119	CbGbCtD
Azelastine—CYP2C9—Capecitabine—breast cancer	0.00442	0.0112	CbGbCtD
Azelastine—CYP3A4—Ixabepilone—breast cancer	0.00429	0.0109	CbGbCtD
Azelastine—CYP2C19—Tamoxifen—breast cancer	0.00428	0.0109	CbGbCtD
Azelastine—CYP3A4—Lapatinib—breast cancer	0.00413	0.0105	CbGbCtD
Azelastine—CYP3A5—Paclitaxel—breast cancer	0.00413	0.0105	CbGbCtD
Azelastine—CYP3A5—Irinotecan—breast cancer	0.00407	0.0104	CbGbCtD
Azelastine—CYP2C8—Paclitaxel—breast cancer	0.00397	0.0101	CbGbCtD
Azelastine—CYP1A2—Tamoxifen—breast cancer	0.00395	0.01	CbGbCtD
Azelastine—ABCB1—Vinorelbine—breast cancer	0.00382	0.00972	CbGbCtD
Azelastine—CYP2C8—Fluorouracil—breast cancer	0.00376	0.00955	CbGbCtD
Azelastine—CYP2D6—Vinorelbine—breast cancer	0.0036	0.00916	CbGbCtD
Azelastine—CYP2C9—Tamoxifen—breast cancer	0.00356	0.00904	CbGbCtD
Azelastine—ABCB1—Tamoxifen—breast cancer	0.00345	0.00878	CbGbCtD
Azelastine—ABCB1—Mitoxantrone—breast cancer	0.00337	0.00856	CbGbCtD
Azelastine—CYP2D6—Tamoxifen—breast cancer	0.00325	0.00827	CbGbCtD
Azelastine—CYP3A4—Raloxifene—breast cancer	0.00313	0.00796	CbGbCtD
Azelastine—CYP3A5—Docetaxel—breast cancer	0.00298	0.00759	CbGbCtD
Azelastine—ABCB1—Gemcitabine—breast cancer	0.00297	0.00756	CbGbCtD
Azelastine—CYP1A2—Fluorouracil—breast cancer	0.00291	0.0074	CbGbCtD
Azelastine—CYP2B6—Doxorubicin—breast cancer	0.00282	0.00718	CbGbCtD
Azelastine—CYP2C9—Paclitaxel—breast cancer	0.00277	0.00704	CbGbCtD
Azelastine—ABCB1—Paclitaxel—breast cancer	0.00269	0.00683	CbGbCtD
Azelastine—ABCB1—Irinotecan—breast cancer	0.00265	0.00674	CbGbCtD
Azelastine—CYP2C9—Fluorouracil—breast cancer	0.00262	0.00666	CbGbCtD
Azelastine—ABCB1—Vinblastine—breast cancer	0.00236	0.00599	CbGbCtD
Azelastine—CYP3A4—Vinorelbine—breast cancer	0.00229	0.00582	CbGbCtD
Azelastine—CYP2D6—Vinblastine—breast cancer	0.00222	0.00564	CbGbCtD
Azelastine—CYP3A4—Tamoxifen—breast cancer	0.00207	0.00526	CbGbCtD
Azelastine—CYP3A4—Mitoxantrone—breast cancer	0.00202	0.00513	CbGbCtD
Azelastine—ABCB1—Docetaxel—breast cancer	0.00194	0.00494	CbGbCtD
Azelastine—CYP3A4—Paclitaxel—breast cancer	0.00161	0.00409	CbGbCtD
Azelastine—CYP3A4—Irinotecan—breast cancer	0.00159	0.00404	CbGbCtD
Azelastine—ABCB1—Doxorubicin—breast cancer	0.00145	0.00368	CbGbCtD
Azelastine—CYP3A4—Vinblastine—breast cancer	0.00141	0.00359	CbGbCtD
Azelastine—ABCB1—Methotrexate—breast cancer	0.0014	0.00357	CbGbCtD
Azelastine—CYP2D6—Doxorubicin—breast cancer	0.00136	0.00347	CbGbCtD
Azelastine—CYP3A4—Docetaxel—breast cancer	0.00116	0.00296	CbGbCtD
Azelastine—CYP3A4—Doxorubicin—breast cancer	0.000868	0.00221	CbGbCtD
Azelastine—CYP2C8—mammary gland—breast cancer	0.000254	0.038	CbGeAlD
Azelastine—KCNH2—nipple—breast cancer	0.00023	0.0344	CbGeAlD
Azelastine—CYP2C9—mammary gland—breast cancer	0.000226	0.0338	CbGeAlD
Azelastine—CYP2A6—adipose tissue—breast cancer	0.000204	0.0305	CbGeAlD
Azelastine—CYP1A2—nipple—breast cancer	0.000197	0.0294	CbGeAlD
Azelastine—CYP1A1—nipple—breast cancer	0.000194	0.029	CbGeAlD
Azelastine—HRH1—nipple—breast cancer	0.000184	0.0276	CbGeAlD
Azelastine—KCNH2—endometrium—breast cancer	0.000139	0.0208	CbGeAlD
Azelastine—CYP1A1—epithelium—breast cancer	0.000131	0.0196	CbGeAlD
Azelastine—KCNH2—uterus—breast cancer	0.000128	0.0191	CbGeAlD
Azelastine—CYP2C8—endometrium—breast cancer	0.000127	0.019	CbGeAlD
Azelastine—KCNH2—pituitary gland—breast cancer	0.000126	0.0188	CbGeAlD
Azelastine—CYP1A1—skin of body—breast cancer	0.000124	0.0186	CbGeAlD
Azelastine—HRH1—epithelium—breast cancer	0.000124	0.0186	CbGeAlD
Azelastine—CYP2B6—skin of body—breast cancer	0.000121	0.0181	CbGeAlD
Azelastine—KCNH2—female reproductive system—breast cancer	0.000115	0.0172	CbGeAlD
Azelastine—CYP2C8—pituitary gland—breast cancer	0.000115	0.0172	CbGeAlD
Azelastine—Clemastine—CYP2D6—breast cancer	0.000115	0.26	CrCbGaD
Azelastine—KCNH2—adrenal gland—breast cancer	0.000112	0.0168	CbGeAlD
Azelastine—HRH1—endometrium—breast cancer	0.000111	0.0166	CbGeAlD
Azelastine—KCNH2—bone marrow—breast cancer	0.000109	0.0162	CbGeAlD
Azelastine—CYP1A1—uterus—breast cancer	0.000108	0.0162	CbGeAlD
Azelastine—CYP1A1—adipose tissue—breast cancer	0.000106	0.0158	CbGeAlD
Azelastine—CYP2C8—female reproductive system—breast cancer	0.000105	0.0157	CbGeAlD
Azelastine—KCNH2—female gonad—breast cancer	0.000105	0.0157	CbGeAlD
Azelastine—CYP3A5—adipose tissue—breast cancer	0.000103	0.0155	CbGeAlD
Azelastine—CYP2C19—endocrine gland—breast cancer	0.000102	0.0153	CbGeAlD
Azelastine—HRH1—adipose tissue—breast cancer	0.0001	0.015	CbGeAlD
Azelastine—Clemastine—CYP3A4—breast cancer	9.84e-05	0.223	CrCbGaD
Azelastine—KCNH2—endocrine gland—breast cancer	9.73e-05	0.0146	CbGeAlD
Azelastine—CYP1A1—female reproductive system—breast cancer	9.71e-05	0.0145	CbGeAlD
Azelastine—CYP2B6—female reproductive system—breast cancer	9.44e-05	0.0141	CbGeAlD
Azelastine—CYP2C9—female reproductive system—breast cancer	9.35e-05	0.014	CbGeAlD
Azelastine—HRH1—female reproductive system—breast cancer	9.22e-05	0.0138	CbGeAlD
Azelastine—CYP2B6—adrenal gland—breast cancer	9.21e-05	0.0138	CbGeAlD
Azelastine—HRH1—adrenal gland—breast cancer	9e-05	0.0135	CbGeAlD
Azelastine—CYP2C8—endocrine gland—breast cancer	8.9e-05	0.0133	CbGeAlD
Azelastine—CYP2E1—female reproductive system—breast cancer	8.86e-05	0.0132	CbGeAlD
Azelastine—CYP1A1—female gonad—breast cancer	8.84e-05	0.0132	CbGeAlD
Azelastine—CYP2E1—adrenal gland—breast cancer	8.64e-05	0.0129	CbGeAlD
Azelastine—CYP3A5—female gonad—breast cancer	8.64e-05	0.0129	CbGeAlD
Azelastine—HRH1—female gonad—breast cancer	8.39e-05	0.0125	CbGeAlD
Azelastine—CYP1A2—endocrine gland—breast cancer	8.33e-05	0.0125	CbGeAlD
Azelastine—ABCB1—embryo—breast cancer	8.32e-05	0.0124	CbGeAlD
Azelastine—CYP1A1—endocrine gland—breast cancer	8.22e-05	0.0123	CbGeAlD
Azelastine—CYP3A5—endocrine gland—breast cancer	8.04e-05	0.012	CbGeAlD
Azelastine—CYP2B6—endocrine gland—breast cancer	7.99e-05	0.0119	CbGeAlD
Azelastine—CYP2C9—endocrine gland—breast cancer	7.91e-05	0.0118	CbGeAlD
Azelastine—HRH1—endocrine gland—breast cancer	7.8e-05	0.0117	CbGeAlD
Azelastine—CYP2E1—endocrine gland—breast cancer	7.5e-05	0.0112	CbGeAlD
Azelastine—Clozapine—CYP1B1—breast cancer	7.5e-05	0.17	CrCbGaD
Azelastine—CYP3A4—female reproductive system—breast cancer	7.13e-05	0.0107	CbGeAlD
Azelastine—CYP2D6—female reproductive system—breast cancer	7.01e-05	0.0105	CbGeAlD
Azelastine—ABCB1—epithelium—breast cancer	6.79e-05	0.0102	CbGeAlD
Azelastine—KCNH2—lymph node—breast cancer	6.73e-05	0.0101	CbGeAlD
Azelastine—CYP2D6—female gonad—breast cancer	6.38e-05	0.00955	CbGeAlD
Azelastine—ABCB1—endometrium—breast cancer	6.09e-05	0.00911	CbGeAlD
Azelastine—CYP3A4—endocrine gland—breast cancer	6.03e-05	0.00902	CbGeAlD
Azelastine—CYP2D6—endocrine gland—breast cancer	5.93e-05	0.00888	CbGeAlD
Azelastine—CYP1A1—lymph node—breast cancer	5.68e-05	0.0085	CbGeAlD
Azelastine—ABCB1—uterus—breast cancer	5.61e-05	0.00839	CbGeAlD
Azelastine—ABCB1—pituitary gland—breast cancer	5.51e-05	0.00824	CbGeAlD
Azelastine—ABCB1—adipose tissue—breast cancer	5.49e-05	0.00821	CbGeAlD
Azelastine—HRH1—lymph node—breast cancer	5.39e-05	0.00807	CbGeAlD
Azelastine—ABCB1—female reproductive system—breast cancer	5.04e-05	0.00755	CbGeAlD
Azelastine—ABCB1—adrenal gland—breast cancer	4.92e-05	0.00736	CbGeAlD
Azelastine—ABCB1—bone marrow—breast cancer	4.76e-05	0.00712	CbGeAlD
Azelastine—ABCB1—female gonad—breast cancer	4.59e-05	0.00687	CbGeAlD
Azelastine—ABCB1—endocrine gland—breast cancer	4.27e-05	0.00639	CbGeAlD
Azelastine—Nausea—Vinorelbine—breast cancer	4.12e-05	0.000376	CcSEcCtD
Azelastine—Asthenia—Mitoxantrone—breast cancer	4.11e-05	0.000374	CcSEcCtD
Azelastine—Asthenia—Irinotecan—breast cancer	4.11e-05	0.000374	CcSEcCtD
Azelastine—Cough—Capecitabine—breast cancer	4.1e-05	0.000373	CcSEcCtD
Azelastine—Conjunctivitis—Epirubicin—breast cancer	4.07e-05	0.000371	CcSEcCtD
Azelastine—Hypertension—Capecitabine—breast cancer	4.05e-05	0.000369	CcSEcCtD
Azelastine—Clozapine—CYP1A1—breast cancer	4.05e-05	0.0917	CrCbGaD
Azelastine—Hypersensitivity—Fluorouracil—breast cancer	4.04e-05	0.000368	CcSEcCtD
Azelastine—Dry mouth—Docetaxel—breast cancer	4.04e-05	0.000368	CcSEcCtD
Azelastine—Upper respiratory tract infection—Doxorubicin—breast cancer	4.04e-05	0.000368	CcSEcCtD
Azelastine—Fatigue—Paclitaxel—breast cancer	4.02e-05	0.000367	CcSEcCtD
Azelastine—Pollakiuria—Doxorubicin—breast cancer	4.01e-05	0.000366	CcSEcCtD
Azelastine—Asthenia—Gemcitabine—breast cancer	4e-05	0.000365	CcSEcCtD
Azelastine—Chest pain—Capecitabine—breast cancer	4e-05	0.000364	CcSEcCtD
Azelastine—Myalgia—Capecitabine—breast cancer	4e-05	0.000364	CcSEcCtD
Azelastine—Pain—Paclitaxel—breast cancer	3.99e-05	0.000364	CcSEcCtD
Azelastine—Constipation—Paclitaxel—breast cancer	3.99e-05	0.000364	CcSEcCtD
Azelastine—Haematuria—Epirubicin—breast cancer	3.99e-05	0.000364	CcSEcCtD
Azelastine—Confusional state—Docetaxel—breast cancer	3.99e-05	0.000364	CcSEcCtD
Azelastine—Pharyngitis—Methotrexate—breast cancer	3.98e-05	0.000363	CcSEcCtD
Azelastine—Anxiety—Capecitabine—breast cancer	3.98e-05	0.000363	CcSEcCtD
Azelastine—Anaphylactic shock—Docetaxel—breast cancer	3.96e-05	0.000361	CcSEcCtD
Azelastine—Weight increased—Doxorubicin—breast cancer	3.95e-05	0.00036	CcSEcCtD
Azelastine—Discomfort—Capecitabine—breast cancer	3.95e-05	0.00036	CcSEcCtD
Azelastine—Epistaxis—Epirubicin—breast cancer	3.95e-05	0.00036	CcSEcCtD
Azelastine—Pruritus—Gemcitabine—breast cancer	3.94e-05	0.00036	CcSEcCtD
Azelastine—Nausea—Thiotepa—breast cancer	3.94e-05	0.000359	CcSEcCtD
Azelastine—Infection—Docetaxel—breast cancer	3.93e-05	0.000358	CcSEcCtD
Azelastine—Sinusitis—Epirubicin—breast cancer	3.93e-05	0.000358	CcSEcCtD
Azelastine—Diarrhoea—Irinotecan—breast cancer	3.92e-05	0.000357	CcSEcCtD
Azelastine—Diarrhoea—Mitoxantrone—breast cancer	3.92e-05	0.000357	CcSEcCtD
Azelastine—Dry mouth—Capecitabine—breast cancer	3.91e-05	0.000356	CcSEcCtD
Azelastine—Pruritus—Fluorouracil—breast cancer	3.88e-05	0.000354	CcSEcCtD
Azelastine—Visual impairment—Methotrexate—breast cancer	3.87e-05	0.000353	CcSEcCtD
Azelastine—Confusional state—Capecitabine—breast cancer	3.86e-05	0.000352	CcSEcCtD
Azelastine—Tachycardia—Docetaxel—breast cancer	3.86e-05	0.000352	CcSEcCtD
Azelastine—Feeling abnormal—Paclitaxel—breast cancer	3.85e-05	0.000351	CcSEcCtD
Azelastine—Gastrointestinal pain—Paclitaxel—breast cancer	3.82e-05	0.000348	CcSEcCtD
Azelastine—Diarrhoea—Gemcitabine—breast cancer	3.81e-05	0.000348	CcSEcCtD
Azelastine—Infection—Capecitabine—breast cancer	3.81e-05	0.000347	CcSEcCtD
Azelastine—Dizziness—Irinotecan—breast cancer	3.78e-05	0.000345	CcSEcCtD
Azelastine—Rhinitis—Epirubicin—breast cancer	3.77e-05	0.000343	CcSEcCtD
Azelastine—Conjunctivitis—Doxorubicin—breast cancer	3.76e-05	0.000343	CcSEcCtD
Azelastine—Eye disorder—Methotrexate—breast cancer	3.75e-05	0.000342	CcSEcCtD
Azelastine—Diarrhoea—Fluorouracil—breast cancer	3.75e-05	0.000342	CcSEcCtD
Azelastine—Tachycardia—Capecitabine—breast cancer	3.74e-05	0.000341	CcSEcCtD
Azelastine—Hypoaesthesia—Epirubicin—breast cancer	3.74e-05	0.000341	CcSEcCtD
Azelastine—Pharyngitis—Epirubicin—breast cancer	3.73e-05	0.00034	CcSEcCtD
Azelastine—Haematuria—Doxorubicin—breast cancer	3.69e-05	0.000337	CcSEcCtD
Azelastine—Abdominal pain—Paclitaxel—breast cancer	3.69e-05	0.000336	CcSEcCtD
Azelastine—Body temperature increased—Paclitaxel—breast cancer	3.69e-05	0.000336	CcSEcCtD
Azelastine—Epistaxis—Doxorubicin—breast cancer	3.65e-05	0.000333	CcSEcCtD
Azelastine—Vomiting—Mitoxantrone—breast cancer	3.64e-05	0.000332	CcSEcCtD
Azelastine—Vomiting—Irinotecan—breast cancer	3.64e-05	0.000332	CcSEcCtD
Azelastine—Sinusitis—Doxorubicin—breast cancer	3.63e-05	0.000331	CcSEcCtD
Azelastine—Dizziness—Fluorouracil—breast cancer	3.62e-05	0.00033	CcSEcCtD
Azelastine—Visual impairment—Epirubicin—breast cancer	3.62e-05	0.00033	CcSEcCtD
Azelastine—Rash—Irinotecan—breast cancer	3.61e-05	0.000329	CcSEcCtD
Azelastine—Rash—Mitoxantrone—breast cancer	3.61e-05	0.000329	CcSEcCtD
Azelastine—Dermatitis—Mitoxantrone—breast cancer	3.6e-05	0.000329	CcSEcCtD
Azelastine—Dermatitis—Irinotecan—breast cancer	3.6e-05	0.000329	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Docetaxel—breast cancer	3.6e-05	0.000329	CcSEcCtD
Azelastine—Headache—Mitoxantrone—breast cancer	3.59e-05	0.000327	CcSEcCtD
Azelastine—Headache—Irinotecan—breast cancer	3.59e-05	0.000327	CcSEcCtD
Azelastine—Paraesthesia—Docetaxel—breast cancer	3.55e-05	0.000324	CcSEcCtD
Azelastine—Vomiting—Gemcitabine—breast cancer	3.54e-05	0.000323	CcSEcCtD
Azelastine—Prazepam—CYP3A4—breast cancer	3.53e-05	0.08	CrCbGaD
Azelastine—Dyspnoea—Docetaxel—breast cancer	3.53e-05	0.000322	CcSEcCtD
Azelastine—Somnolence—Docetaxel—breast cancer	3.52e-05	0.000321	CcSEcCtD
Azelastine—Rash—Gemcitabine—breast cancer	3.51e-05	0.00032	CcSEcCtD
Azelastine—Dermatitis—Gemcitabine—breast cancer	3.51e-05	0.00032	CcSEcCtD
Azelastine—Eye disorder—Epirubicin—breast cancer	3.51e-05	0.00032	CcSEcCtD
Azelastine—Headache—Gemcitabine—breast cancer	3.49e-05	0.000318	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Capecitabine—breast cancer	3.49e-05	0.000318	CcSEcCtD
Azelastine—Flushing—Epirubicin—breast cancer	3.49e-05	0.000318	CcSEcCtD
Azelastine—Vomiting—Fluorouracil—breast cancer	3.48e-05	0.000318	CcSEcCtD
Azelastine—Rhinitis—Doxorubicin—breast cancer	3.48e-05	0.000318	CcSEcCtD
Azelastine—Hypoaesthesia—Doxorubicin—breast cancer	3.46e-05	0.000315	CcSEcCtD
Azelastine—Rash—Fluorouracil—breast cancer	3.46e-05	0.000315	CcSEcCtD
Azelastine—Dermatitis—Fluorouracil—breast cancer	3.45e-05	0.000315	CcSEcCtD
Azelastine—Pharyngitis—Doxorubicin—breast cancer	3.45e-05	0.000314	CcSEcCtD
Azelastine—Paraesthesia—Capecitabine—breast cancer	3.44e-05	0.000314	CcSEcCtD
Azelastine—Hypersensitivity—Paclitaxel—breast cancer	3.44e-05	0.000314	CcSEcCtD
Azelastine—Headache—Fluorouracil—breast cancer	3.43e-05	0.000313	CcSEcCtD
Azelastine—Dysgeusia—Methotrexate—breast cancer	3.42e-05	0.000312	CcSEcCtD
Azelastine—Dyspnoea—Capecitabine—breast cancer	3.41e-05	0.000311	CcSEcCtD
Azelastine—Fatigue—Docetaxel—breast cancer	3.41e-05	0.000311	CcSEcCtD
Azelastine—Nausea—Mitoxantrone—breast cancer	3.4e-05	0.00031	CcSEcCtD
Azelastine—Nausea—Irinotecan—breast cancer	3.4e-05	0.00031	CcSEcCtD
Azelastine—Pain—Docetaxel—breast cancer	3.38e-05	0.000308	CcSEcCtD
Azelastine—Constipation—Docetaxel—breast cancer	3.38e-05	0.000308	CcSEcCtD
Azelastine—Back pain—Methotrexate—breast cancer	3.38e-05	0.000308	CcSEcCtD
Azelastine—Visual impairment—Doxorubicin—breast cancer	3.35e-05	0.000305	CcSEcCtD
Azelastine—Asthenia—Paclitaxel—breast cancer	3.35e-05	0.000305	CcSEcCtD
Azelastine—Nausea—Gemcitabine—breast cancer	3.31e-05	0.000302	CcSEcCtD
Azelastine—Fatigue—Capecitabine—breast cancer	3.3e-05	0.000301	CcSEcCtD
Azelastine—Pruritus—Paclitaxel—breast cancer	3.3e-05	0.000301	CcSEcCtD
Azelastine—Vision blurred—Methotrexate—breast cancer	3.29e-05	0.0003	CcSEcCtD
Azelastine—Constipation—Capecitabine—breast cancer	3.28e-05	0.000299	CcSEcCtD
Azelastine—Pain—Capecitabine—breast cancer	3.28e-05	0.000299	CcSEcCtD
Azelastine—Feeling abnormal—Docetaxel—breast cancer	3.26e-05	0.000297	CcSEcCtD
Azelastine—Nausea—Fluorouracil—breast cancer	3.26e-05	0.000297	CcSEcCtD
Azelastine—Eye disorder—Doxorubicin—breast cancer	3.25e-05	0.000296	CcSEcCtD
Azelastine—Ill-defined disorder—Methotrexate—breast cancer	3.24e-05	0.000296	CcSEcCtD
Azelastine—Gastrointestinal pain—Docetaxel—breast cancer	3.23e-05	0.000295	CcSEcCtD
Azelastine—Flushing—Doxorubicin—breast cancer	3.23e-05	0.000294	CcSEcCtD
Azelastine—Tension—Epirubicin—breast cancer	3.21e-05	0.000293	CcSEcCtD
Azelastine—Dysgeusia—Epirubicin—breast cancer	3.2e-05	0.000292	CcSEcCtD
Azelastine—Diarrhoea—Paclitaxel—breast cancer	3.19e-05	0.000291	CcSEcCtD
Azelastine—Nervousness—Epirubicin—breast cancer	3.18e-05	0.00029	CcSEcCtD
Azelastine—Back pain—Epirubicin—breast cancer	3.16e-05	0.000288	CcSEcCtD
Azelastine—Feeling abnormal—Capecitabine—breast cancer	3.16e-05	0.000288	CcSEcCtD
Azelastine—Malaise—Methotrexate—breast cancer	3.15e-05	0.000287	CcSEcCtD
Azelastine—Vertigo—Methotrexate—breast cancer	3.14e-05	0.000286	CcSEcCtD
Azelastine—Gastrointestinal pain—Capecitabine—breast cancer	3.13e-05	0.000286	CcSEcCtD
Azelastine—Abdominal pain—Docetaxel—breast cancer	3.13e-05	0.000285	CcSEcCtD
Azelastine—Body temperature increased—Docetaxel—breast cancer	3.13e-05	0.000285	CcSEcCtD
Azelastine—Dizziness—Paclitaxel—breast cancer	3.09e-05	0.000281	CcSEcCtD
Azelastine—Vision blurred—Epirubicin—breast cancer	3.08e-05	0.000281	CcSEcCtD
Azelastine—Cough—Methotrexate—breast cancer	3.05e-05	0.000278	CcSEcCtD
Azelastine—Ill-defined disorder—Epirubicin—breast cancer	3.03e-05	0.000277	CcSEcCtD
Azelastine—Abdominal pain—Capecitabine—breast cancer	3.03e-05	0.000276	CcSEcCtD
Azelastine—Body temperature increased—Capecitabine—breast cancer	3.03e-05	0.000276	CcSEcCtD
Azelastine—Clozapine—CYP2D6—breast cancer	3.01e-05	0.0682	CrCbGaD
Azelastine—Agitation—Epirubicin—breast cancer	3e-05	0.000274	CcSEcCtD
Azelastine—Chest pain—Methotrexate—breast cancer	2.97e-05	0.000271	CcSEcCtD
Azelastine—Myalgia—Methotrexate—breast cancer	2.97e-05	0.000271	CcSEcCtD
Azelastine—Tension—Doxorubicin—breast cancer	2.97e-05	0.000271	CcSEcCtD
Azelastine—Vomiting—Paclitaxel—breast cancer	2.97e-05	0.000271	CcSEcCtD
Azelastine—Dysgeusia—Doxorubicin—breast cancer	2.96e-05	0.00027	CcSEcCtD
Azelastine—ABCB1—lymph node—breast cancer	2.95e-05	0.00441	CbGeAlD
Azelastine—Malaise—Epirubicin—breast cancer	2.95e-05	0.000269	CcSEcCtD
Azelastine—Rash—Paclitaxel—breast cancer	2.94e-05	0.000268	CcSEcCtD
Azelastine—Dermatitis—Paclitaxel—breast cancer	2.94e-05	0.000268	CcSEcCtD
Azelastine—Discomfort—Methotrexate—breast cancer	2.94e-05	0.000268	CcSEcCtD
Azelastine—Nervousness—Doxorubicin—breast cancer	2.94e-05	0.000268	CcSEcCtD
Azelastine—Vertigo—Epirubicin—breast cancer	2.94e-05	0.000268	CcSEcCtD
Azelastine—Back pain—Doxorubicin—breast cancer	2.93e-05	0.000267	CcSEcCtD
Azelastine—Headache—Paclitaxel—breast cancer	2.92e-05	0.000267	CcSEcCtD
Azelastine—Hypersensitivity—Docetaxel—breast cancer	2.91e-05	0.000266	CcSEcCtD
Azelastine—Palpitations—Epirubicin—breast cancer	2.89e-05	0.000263	CcSEcCtD
Azelastine—Confusional state—Methotrexate—breast cancer	2.87e-05	0.000262	CcSEcCtD
Azelastine—Cough—Epirubicin—breast cancer	2.85e-05	0.00026	CcSEcCtD
Azelastine—Anaphylactic shock—Methotrexate—breast cancer	2.85e-05	0.00026	CcSEcCtD
Azelastine—Vision blurred—Doxorubicin—breast cancer	2.85e-05	0.00026	CcSEcCtD
Azelastine—Asthenia—Docetaxel—breast cancer	2.84e-05	0.000259	CcSEcCtD
Azelastine—Infection—Methotrexate—breast cancer	2.83e-05	0.000258	CcSEcCtD
Azelastine—Hypertension—Epirubicin—breast cancer	2.82e-05	0.000257	CcSEcCtD
Azelastine—Hypersensitivity—Capecitabine—breast cancer	2.82e-05	0.000257	CcSEcCtD
Azelastine—Ill-defined disorder—Doxorubicin—breast cancer	2.81e-05	0.000256	CcSEcCtD
Azelastine—Pruritus—Docetaxel—breast cancer	2.8e-05	0.000255	CcSEcCtD
Azelastine—Chest pain—Epirubicin—breast cancer	2.78e-05	0.000254	CcSEcCtD
Azelastine—Myalgia—Epirubicin—breast cancer	2.78e-05	0.000254	CcSEcCtD
Azelastine—Agitation—Doxorubicin—breast cancer	2.78e-05	0.000253	CcSEcCtD
Azelastine—Anxiety—Epirubicin—breast cancer	2.77e-05	0.000253	CcSEcCtD
Azelastine—Nausea—Paclitaxel—breast cancer	2.77e-05	0.000253	CcSEcCtD
Azelastine—Discomfort—Epirubicin—breast cancer	2.75e-05	0.000251	CcSEcCtD
Azelastine—Asthenia—Capecitabine—breast cancer	2.75e-05	0.000251	CcSEcCtD
Azelastine—Malaise—Doxorubicin—breast cancer	2.73e-05	0.000249	CcSEcCtD
Azelastine—Dry mouth—Epirubicin—breast cancer	2.72e-05	0.000248	CcSEcCtD
Azelastine—Vertigo—Doxorubicin—breast cancer	2.72e-05	0.000248	CcSEcCtD
Azelastine—Pruritus—Capecitabine—breast cancer	2.71e-05	0.000247	CcSEcCtD
Azelastine—Diarrhoea—Docetaxel—breast cancer	2.71e-05	0.000247	CcSEcCtD
Azelastine—Confusional state—Epirubicin—breast cancer	2.69e-05	0.000245	CcSEcCtD
Azelastine—Palpitations—Doxorubicin—breast cancer	2.67e-05	0.000244	CcSEcCtD
Azelastine—Anaphylactic shock—Epirubicin—breast cancer	2.67e-05	0.000243	CcSEcCtD
Azelastine—Infection—Epirubicin—breast cancer	2.65e-05	0.000242	CcSEcCtD
Azelastine—Cough—Doxorubicin—breast cancer	2.64e-05	0.000241	CcSEcCtD
Azelastine—Diarrhoea—Capecitabine—breast cancer	2.62e-05	0.000239	CcSEcCtD
Azelastine—Dizziness—Docetaxel—breast cancer	2.62e-05	0.000239	CcSEcCtD
Azelastine—Hypertension—Doxorubicin—breast cancer	2.61e-05	0.000238	CcSEcCtD
Azelastine—Tachycardia—Epirubicin—breast cancer	2.6e-05	0.000237	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Methotrexate—breast cancer	2.6e-05	0.000237	CcSEcCtD
Azelastine—Clozapine—CYP3A4—breast cancer	2.58e-05	0.0585	CrCbGaD
Azelastine—Chest pain—Doxorubicin—breast cancer	2.58e-05	0.000235	CcSEcCtD
Azelastine—Myalgia—Doxorubicin—breast cancer	2.58e-05	0.000235	CcSEcCtD
Azelastine—Anxiety—Doxorubicin—breast cancer	2.57e-05	0.000234	CcSEcCtD
Azelastine—Paraesthesia—Methotrexate—breast cancer	2.56e-05	0.000233	CcSEcCtD
Azelastine—Discomfort—Doxorubicin—breast cancer	2.54e-05	0.000232	CcSEcCtD
Azelastine—Dyspnoea—Methotrexate—breast cancer	2.54e-05	0.000232	CcSEcCtD
Azelastine—Somnolence—Methotrexate—breast cancer	2.53e-05	0.000231	CcSEcCtD
Azelastine—Dizziness—Capecitabine—breast cancer	2.53e-05	0.000231	CcSEcCtD
Azelastine—Dry mouth—Doxorubicin—breast cancer	2.52e-05	0.00023	CcSEcCtD
Azelastine—Vomiting—Docetaxel—breast cancer	2.52e-05	0.000229	CcSEcCtD
Azelastine—Rash—Docetaxel—breast cancer	2.49e-05	0.000227	CcSEcCtD
Azelastine—Dermatitis—Docetaxel—breast cancer	2.49e-05	0.000227	CcSEcCtD
Azelastine—Confusional state—Doxorubicin—breast cancer	2.49e-05	0.000227	CcSEcCtD
Azelastine—Headache—Docetaxel—breast cancer	2.48e-05	0.000226	CcSEcCtD
Azelastine—Anaphylactic shock—Doxorubicin—breast cancer	2.47e-05	0.000225	CcSEcCtD
Azelastine—Fatigue—Methotrexate—breast cancer	2.46e-05	0.000224	CcSEcCtD
Azelastine—Infection—Doxorubicin—breast cancer	2.45e-05	0.000224	CcSEcCtD
Azelastine—Pain—Methotrexate—breast cancer	2.44e-05	0.000222	CcSEcCtD
Azelastine—Vomiting—Capecitabine—breast cancer	2.44e-05	0.000222	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Epirubicin—breast cancer	2.43e-05	0.000222	CcSEcCtD
Azelastine—Rash—Capecitabine—breast cancer	2.41e-05	0.00022	CcSEcCtD
Azelastine—Dermatitis—Capecitabine—breast cancer	2.41e-05	0.00022	CcSEcCtD
Azelastine—Tachycardia—Doxorubicin—breast cancer	2.41e-05	0.00022	CcSEcCtD
Azelastine—Headache—Capecitabine—breast cancer	2.4e-05	0.000219	CcSEcCtD
Azelastine—Paraesthesia—Epirubicin—breast cancer	2.4e-05	0.000218	CcSEcCtD
Azelastine—Dyspnoea—Epirubicin—breast cancer	2.38e-05	0.000217	CcSEcCtD
Azelastine—Somnolence—Epirubicin—breast cancer	2.37e-05	0.000216	CcSEcCtD
Azelastine—Nausea—Docetaxel—breast cancer	2.35e-05	0.000214	CcSEcCtD
Azelastine—Feeling abnormal—Methotrexate—breast cancer	2.35e-05	0.000214	CcSEcCtD
Azelastine—Gastrointestinal pain—Methotrexate—breast cancer	2.33e-05	0.000213	CcSEcCtD
Azelastine—Fatigue—Epirubicin—breast cancer	2.3e-05	0.00021	CcSEcCtD
Azelastine—Constipation—Epirubicin—breast cancer	2.28e-05	0.000208	CcSEcCtD
Azelastine—Pain—Epirubicin—breast cancer	2.28e-05	0.000208	CcSEcCtD
Azelastine—Nausea—Capecitabine—breast cancer	2.28e-05	0.000207	CcSEcCtD
Azelastine—Body temperature increased—Methotrexate—breast cancer	2.25e-05	0.000206	CcSEcCtD
Azelastine—Abdominal pain—Methotrexate—breast cancer	2.25e-05	0.000206	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.25e-05	0.000205	CcSEcCtD
Azelastine—Paraesthesia—Doxorubicin—breast cancer	2.22e-05	0.000202	CcSEcCtD
Azelastine—Dyspnoea—Doxorubicin—breast cancer	2.2e-05	0.000201	CcSEcCtD
Azelastine—Feeling abnormal—Epirubicin—breast cancer	2.2e-05	0.0002	CcSEcCtD
Azelastine—Somnolence—Doxorubicin—breast cancer	2.19e-05	0.0002	CcSEcCtD
Azelastine—Gastrointestinal pain—Epirubicin—breast cancer	2.18e-05	0.000199	CcSEcCtD
Azelastine—Clozapine—ABCB1—breast cancer	2.15e-05	0.0487	CrCbGaD
Azelastine—Fatigue—Doxorubicin—breast cancer	2.13e-05	0.000194	CcSEcCtD
Azelastine—Constipation—Doxorubicin—breast cancer	2.11e-05	0.000193	CcSEcCtD
Azelastine—Pain—Doxorubicin—breast cancer	2.11e-05	0.000193	CcSEcCtD
Azelastine—Body temperature increased—Epirubicin—breast cancer	2.11e-05	0.000192	CcSEcCtD
Azelastine—Abdominal pain—Epirubicin—breast cancer	2.11e-05	0.000192	CcSEcCtD
Azelastine—Hypersensitivity—Methotrexate—breast cancer	2.1e-05	0.000192	CcSEcCtD
Azelastine—Asthenia—Methotrexate—breast cancer	2.05e-05	0.000187	CcSEcCtD
Azelastine—Feeling abnormal—Doxorubicin—breast cancer	2.03e-05	0.000186	CcSEcCtD
Azelastine—Gastrointestinal pain—Doxorubicin—breast cancer	2.02e-05	0.000184	CcSEcCtD
Azelastine—Pruritus—Methotrexate—breast cancer	2.02e-05	0.000184	CcSEcCtD
Azelastine—Hypersensitivity—Epirubicin—breast cancer	1.97e-05	0.000179	CcSEcCtD
Azelastine—Abdominal pain—Doxorubicin—breast cancer	1.95e-05	0.000178	CcSEcCtD
Azelastine—Body temperature increased—Doxorubicin—breast cancer	1.95e-05	0.000178	CcSEcCtD
Azelastine—Diarrhoea—Methotrexate—breast cancer	1.95e-05	0.000178	CcSEcCtD
Azelastine—Asthenia—Epirubicin—breast cancer	1.91e-05	0.000175	CcSEcCtD
Azelastine—Pruritus—Epirubicin—breast cancer	1.89e-05	0.000172	CcSEcCtD
Azelastine—Dizziness—Methotrexate—breast cancer	1.89e-05	0.000172	CcSEcCtD
Azelastine—Diarrhoea—Epirubicin—breast cancer	1.83e-05	0.000166	CcSEcCtD
Azelastine—Hypersensitivity—Doxorubicin—breast cancer	1.82e-05	0.000166	CcSEcCtD
Azelastine—Vomiting—Methotrexate—breast cancer	1.81e-05	0.000165	CcSEcCtD
Azelastine—Rash—Methotrexate—breast cancer	1.8e-05	0.000164	CcSEcCtD
Azelastine—Dermatitis—Methotrexate—breast cancer	1.8e-05	0.000164	CcSEcCtD
Azelastine—Headache—Methotrexate—breast cancer	1.79e-05	0.000163	CcSEcCtD
Azelastine—Asthenia—Doxorubicin—breast cancer	1.77e-05	0.000162	CcSEcCtD
Azelastine—Dizziness—Epirubicin—breast cancer	1.76e-05	0.000161	CcSEcCtD
Azelastine—Pruritus—Doxorubicin—breast cancer	1.75e-05	0.000159	CcSEcCtD
Azelastine—Vomiting—Epirubicin—breast cancer	1.7e-05	0.000155	CcSEcCtD
Azelastine—Nausea—Methotrexate—breast cancer	1.69e-05	0.000154	CcSEcCtD
Azelastine—Diarrhoea—Doxorubicin—breast cancer	1.69e-05	0.000154	CcSEcCtD
Azelastine—Rash—Epirubicin—breast cancer	1.68e-05	0.000153	CcSEcCtD
Azelastine—Dermatitis—Epirubicin—breast cancer	1.68e-05	0.000153	CcSEcCtD
Azelastine—Headache—Epirubicin—breast cancer	1.67e-05	0.000152	CcSEcCtD
Azelastine—Dizziness—Doxorubicin—breast cancer	1.63e-05	0.000149	CcSEcCtD
Azelastine—Nausea—Epirubicin—breast cancer	1.58e-05	0.000145	CcSEcCtD
Azelastine—Vomiting—Doxorubicin—breast cancer	1.57e-05	0.000143	CcSEcCtD
Azelastine—Rash—Doxorubicin—breast cancer	1.56e-05	0.000142	CcSEcCtD
Azelastine—Dermatitis—Doxorubicin—breast cancer	1.56e-05	0.000142	CcSEcCtD
Azelastine—Headache—Doxorubicin—breast cancer	1.55e-05	0.000141	CcSEcCtD
Azelastine—Nausea—Doxorubicin—breast cancer	1.47e-05	0.000134	CcSEcCtD
Azelastine—CYP2D6—Metabolism—NCOR1—breast cancer	1.52e-06	2.1e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ERCC2—breast cancer	1.52e-06	2.1e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—STK11—breast cancer	1.52e-06	2.09e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP19A1—breast cancer	1.52e-06	2.09e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—KRAS—breast cancer	1.51e-06	2.09e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—CAV1—breast cancer	1.51e-06	2.09e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.51e-06	2.08e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—NCOR1—breast cancer	1.51e-06	2.08e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GSTM1—breast cancer	1.51e-06	2.08e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CG—breast cancer	1.5e-06	2.07e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—BRAF—breast cancer	1.49e-06	2.07e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP17A1—breast cancer	1.48e-06	2.04e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ENO1—breast cancer	1.46e-06	2.02e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS1—breast cancer	1.46e-06	2.02e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—MTHFR—breast cancer	1.46e-06	2.02e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—NOS3—breast cancer	1.46e-06	2.02e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—GPX1—breast cancer	1.46e-06	2.01e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IGF1—breast cancer	1.46e-06	2.01e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT2—breast cancer	1.45e-06	2.01e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—EGFR—breast cancer	1.45e-06	2e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—GPX1—breast cancer	1.44e-06	2e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.44e-06	1.99e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CYP1A1—breast cancer	1.44e-06	1.99e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP2D6—breast cancer	1.43e-06	1.98e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ERCC2—breast cancer	1.43e-06	1.98e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CYP1A1—breast cancer	1.43e-06	1.98e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CD—breast cancer	1.43e-06	1.97e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—MTHFR—breast cancer	1.43e-06	1.97e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.42e-06	1.97e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ERCC2—breast cancer	1.42e-06	1.96e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—ALB—breast cancer	1.41e-06	1.95e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—COMT—breast cancer	1.41e-06	1.95e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NCOA2—breast cancer	1.41e-06	1.95e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTP1—breast cancer	1.4e-06	1.94e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CD—breast cancer	1.4e-06	1.93e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CD—breast cancer	1.4e-06	1.93e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CD—breast cancer	1.4e-06	1.93e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—PIK3CA—breast cancer	1.39e-06	1.92e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	1.38e-06	1.91e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MDM2—breast cancer	1.38e-06	1.91e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—HMOX1—breast cancer	1.38e-06	1.91e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SERPINE1—breast cancer	1.38e-06	1.91e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—ALB—breast cancer	1.38e-06	1.91e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ITPR1—breast cancer	1.38e-06	1.91e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—ALB—breast cancer	1.38e-06	1.91e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—RAF1—breast cancer	1.38e-06	1.91e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CG—breast cancer	1.38e-06	1.9e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—RELA—breast cancer	1.37e-06	1.9e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—KRAS—breast cancer	1.37e-06	1.89e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—FASN—breast cancer	1.37e-06	1.89e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—ERBB2—breast cancer	1.36e-06	1.88e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—BCHE—breast cancer	1.36e-06	1.88e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—NOS3—breast cancer	1.35e-06	1.86e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—CAV1—breast cancer	1.35e-06	1.86e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CB—breast cancer	1.35e-06	1.86e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MTOR—breast cancer	1.35e-06	1.86e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—MTHFR—breast cancer	1.34e-06	1.86e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SLC5A5—breast cancer	1.34e-06	1.86e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PTEN—breast cancer	1.33e-06	1.84e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—MTHFR—breast cancer	1.33e-06	1.84e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ABCB1—breast cancer	1.33e-06	1.83e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—NOS3—breast cancer	1.32e-06	1.83e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—NOS3—breast cancer	1.32e-06	1.82e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CD—breast cancer	1.32e-06	1.82e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—NOS3—breast cancer	1.32e-06	1.82e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—CAV1—breast cancer	1.32e-06	1.82e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—TYMS—breast cancer	1.3e-06	1.8e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—ALB—breast cancer	1.3e-06	1.8e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NQO1—breast cancer	1.3e-06	1.79e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.3e-06	1.79e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CXCL8—breast cancer	1.29e-06	1.79e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—NCOR1—breast cancer	1.29e-06	1.78e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GSTM1—breast cancer	1.29e-06	1.78e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.29e-06	1.78e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.29e-06	1.78e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—HRAS—breast cancer	1.28e-06	1.78e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	1.26e-06	1.75e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—PIK3CA—breast cancer	1.26e-06	1.74e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MDM2—breast cancer	1.25e-06	1.73e-05	CbGpPWpGaD
Azelastine—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	1.25e-06	1.73e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RAF1—breast cancer	1.25e-06	1.72e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—NOS3—breast cancer	1.25e-06	1.72e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CB—breast cancer	1.25e-06	1.72e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.24e-06	1.72e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—RELA—breast cancer	1.24e-06	1.72e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—CAV1—breast cancer	1.24e-06	1.71e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CASP3—breast cancer	1.24e-06	1.71e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL2—breast cancer	1.24e-06	1.71e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—ERBB2—breast cancer	1.23e-06	1.71e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—GPX1—breast cancer	1.23e-06	1.71e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTGS2—breast cancer	1.23e-06	1.71e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—IL6—breast cancer	1.23e-06	1.7e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—CAV1—breast cancer	1.23e-06	1.7e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CG—breast cancer	1.23e-06	1.7e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CYP1A1—breast cancer	1.22e-06	1.69e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.22e-06	1.69e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CB—breast cancer	1.22e-06	1.69e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MTOR—breast cancer	1.22e-06	1.68e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CB—breast cancer	1.22e-06	1.68e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CB—breast cancer	1.22e-06	1.68e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ERCC2—breast cancer	1.21e-06	1.67e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CD—breast cancer	1.21e-06	1.67e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTGS2—breast cancer	1.21e-06	1.67e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTGS2—breast cancer	1.21e-06	1.67e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CCND1—breast cancer	1.2e-06	1.67e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—JUN—breast cancer	1.2e-06	1.66e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CG—breast cancer	1.2e-06	1.66e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—ALB—breast cancer	1.19e-06	1.65e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	1.19e-06	1.65e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NCOA1—breast cancer	1.19e-06	1.64e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.17e-06	1.62e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CXCL8—breast cancer	1.17e-06	1.62e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MMP9—breast cancer	1.17e-06	1.62e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—STK11—breast cancer	1.17e-06	1.62e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.17e-06	1.62e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	1.17e-06	1.61e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—HRAS—breast cancer	1.16e-06	1.61e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PTEN—breast cancer	1.16e-06	1.61e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CB—breast cancer	1.15e-06	1.59e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CDKN1B—breast cancer	1.14e-06	1.58e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—NOS3—breast cancer	1.14e-06	1.58e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTGS2—breast cancer	1.14e-06	1.57e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—MTHFR—breast cancer	1.14e-06	1.57e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK8—breast cancer	1.14e-06	1.57e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling by GPCR—AKT1—breast cancer	1.13e-06	1.57e-05	CbGpPWpGaD
Azelastine—HRH1—GPCR downstream signaling—AKT1—breast cancer	1.13e-06	1.56e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.13e-06	1.56e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CASP3—breast cancer	1.12e-06	1.55e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CG—breast cancer	1.12e-06	1.55e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL2—breast cancer	1.12e-06	1.55e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—IL6—breast cancer	1.11e-06	1.54e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CCND1—breast cancer	1.09e-06	1.51e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—JUN—breast cancer	1.09e-06	1.5e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—COMT—breast cancer	1.09e-06	1.5e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTP1—breast cancer	1.08e-06	1.5e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CTNNB1—breast cancer	1.08e-06	1.49e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CD—breast cancer	1.08e-06	1.49e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—SRC—breast cancer	1.08e-06	1.49e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PTEN—breast cancer	1.08e-06	1.49e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—HMOX1—breast cancer	1.07e-06	1.48e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—ALB—breast cancer	1.07e-06	1.47e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ITPR1—breast cancer	1.06e-06	1.47e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MMP9—breast cancer	1.06e-06	1.46e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—CDKN1A—breast cancer	1.05e-06	1.46e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CB—breast cancer	1.05e-06	1.46e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PTEN—breast cancer	1.05e-06	1.46e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CD—breast cancer	1.05e-06	1.46e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PTEN—breast cancer	1.05e-06	1.45e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PTEN—breast cancer	1.05e-06	1.45e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—CAV1—breast cancer	1.05e-06	1.45e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	1.05e-06	1.45e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTGS2—breast cancer	1.04e-06	1.44e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—ALB—breast cancer	1.04e-06	1.44e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—STAT3—breast cancer	1.04e-06	1.44e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK8—breast cancer	1.03e-06	1.42e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling by GPCR—AKT1—breast cancer	1.03e-06	1.42e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ABCB1—breast cancer	1.02e-06	1.42e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—NOS3—breast cancer	1.02e-06	1.41e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—TYMS—breast cancer	1.01e-06	1.39e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1e-06	1.39e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—NOS3—breast cancer	9.95e-07	1.38e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GSTM1—breast cancer	9.94e-07	1.37e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NCOR1—breast cancer	9.94e-07	1.37e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PLA2G4A—breast cancer	9.94e-07	1.37e-05	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PTEN—breast cancer	9.93e-07	1.37e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	9.93e-07	1.37e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CD—breast cancer	9.93e-07	1.37e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CD—breast cancer	9.84e-07	1.36e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—ALB—breast cancer	9.8e-07	1.35e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—SRC—breast cancer	9.76e-07	1.35e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—ALB—breast cancer	9.72e-07	1.34e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—MYC—breast cancer	9.66e-07	1.34e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	9.64e-07	1.33e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CG—breast cancer	9.57e-07	1.32e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—GPX1—breast cancer	9.52e-07	1.32e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—VEGFA—breast cancer	9.51e-07	1.31e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—EGFR—breast cancer	9.45e-07	1.31e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CYP1A1—breast cancer	9.43e-07	1.3e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—STAT3—breast cancer	9.41e-07	1.3e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CB—breast cancer	9.41e-07	1.3e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—PIK3CA—breast cancer	9.41e-07	1.3e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—NOS3—breast cancer	9.37e-07	1.3e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ERCC2—breast cancer	9.35e-07	1.29e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTGS2—breast cancer	9.32e-07	1.29e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—NOS3—breast cancer	9.29e-07	1.28e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CB—breast cancer	9.18e-07	1.27e-05	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PTEN—breast cancer	9.11e-07	1.26e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTGS2—breast cancer	9.1e-07	1.26e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MAPK3—breast cancer	8.99e-07	1.24e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—KRAS—breast cancer	8.93e-07	1.23e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—MTHFR—breast cancer	8.79e-07	1.21e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—MYC—breast cancer	8.75e-07	1.21e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TGFB1—breast cancer	8.72e-07	1.21e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CB—breast cancer	8.65e-07	1.2e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CB—breast cancer	8.58e-07	1.19e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTGS2—breast cancer	8.57e-07	1.19e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—EGFR—breast cancer	8.55e-07	1.18e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTGS2—breast cancer	8.5e-07	1.18e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CD—breast cancer	8.41e-07	1.16e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—ALB—breast cancer	8.3e-07	1.15e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	8.2e-07	1.13e-05	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PTEN—breast cancer	8.13e-07	1.12e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—CAV1—breast cancer	8.11e-07	1.12e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—KRAS—breast cancer	8.08e-07	1.12e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—NOS3—breast cancer	7.94e-07	1.1e-05	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PTEN—breast cancer	7.94e-07	1.1e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—TP53—breast cancer	7.93e-07	1.1e-05	CbGpPWpGaD
Azelastine—CYP2A6—Metabolism—AKT1—breast cancer	7.68e-07	1.06e-05	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—PIK3CA—breast cancer	7.59e-07	1.05e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—HRAS—breast cancer	7.59e-07	1.05e-05	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PTEN—breast cancer	7.48e-07	1.03e-05	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—PIK3CA—breast cancer	7.43e-07	1.03e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—PIK3CA—breast cancer	7.42e-07	1.03e-05	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—PIK3CA—breast cancer	7.42e-07	1.03e-05	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PTEN—breast cancer	7.41e-07	1.02e-05	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CG—breast cancer	7.38e-07	1.02e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CB—breast cancer	7.33e-07	1.01e-05	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTGS2—breast cancer	7.26e-07	1e-05	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—IL6—breast cancer	7.26e-07	1e-05	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—TP53—breast cancer	7.18e-07	9.93e-06	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—PIK3CA—breast cancer	7.01e-07	9.69e-06	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—HRAS—breast cancer	6.87e-07	9.5e-06	CbGpPWpGaD
Azelastine—ADRA1B—Signaling Pathways—AKT1—breast cancer	6.7e-07	9.26e-06	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—IL6—breast cancer	6.57e-07	9.09e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CD—breast cancer	6.49e-07	8.97e-06	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—PIK3CA—breast cancer	6.43e-07	8.88e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—ALB—breast cancer	6.41e-07	8.86e-06	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PTEN—breast cancer	6.33e-07	8.76e-06	CbGpPWpGaD
Azelastine—CYP2B6—Metabolism—AKT1—breast cancer	6.2e-07	8.57e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—NOS3—breast cancer	6.13e-07	8.47e-06	CbGpPWpGaD
Azelastine—CYP2E1—Metabolism—AKT1—breast cancer	6.07e-07	8.4e-06	CbGpPWpGaD
Azelastine—HRH1—Signaling Pathways—AKT1—breast cancer	6.07e-07	8.38e-06	CbGpPWpGaD
Azelastine—CYP3A5—Metabolism—AKT1—breast cancer	6.06e-07	8.38e-06	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—PIK3CA—breast cancer	5.74e-07	7.93e-06	CbGpPWpGaD
Azelastine—CYP1A1—Metabolism—AKT1—breast cancer	5.73e-07	7.91e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CB—breast cancer	5.66e-07	7.82e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTGS2—breast cancer	5.61e-07	7.75e-06	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—PIK3CA—breast cancer	5.6e-07	7.74e-06	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—PIK3CA—breast cancer	5.28e-07	7.29e-06	CbGpPWpGaD
Azelastine—CYP2C8—Metabolism—AKT1—breast cancer	5.25e-07	7.26e-06	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—PIK3CA—breast cancer	5.23e-07	7.23e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PTEN—breast cancer	4.89e-07	6.76e-06	CbGpPWpGaD
Azelastine—CYP2C19—Metabolism—AKT1—breast cancer	4.69e-07	6.48e-06	CbGpPWpGaD
Azelastine—ABCB1—Metabolism—AKT1—breast cancer	4.57e-07	6.32e-06	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—PIK3CA—breast cancer	4.47e-07	6.18e-06	CbGpPWpGaD
Azelastine—CYP2D6—Metabolism—AKT1—breast cancer	4.31e-07	5.96e-06	CbGpPWpGaD
Azelastine—CYP2C9—Metabolism—AKT1—breast cancer	4.27e-07	5.91e-06	CbGpPWpGaD
Azelastine—CYP1A2—Metabolism—AKT1—breast cancer	3.65e-07	5.05e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—PIK3CA—breast cancer	3.45e-07	4.77e-06	CbGpPWpGaD
Azelastine—CYP3A4—Metabolism—AKT1—breast cancer	2.82e-07	3.89e-06	CbGpPWpGaD
